115 related articles for article (PubMed ID: 18156504)
1. Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemia.
Rossi D; Rasi S; Capello D; Gaidano G
Blood; 2008 Jan; 111(1):466-8. PubMed ID: 18156504
[No Abstract] [Full Text] [Related]
2. The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia.
Kaderi MA; Norberg M; Murray F; Merup M; Sundström C; Roos G; Aleskog A; Karlsson K; Axelsson T; Tobin G; Rosenquist R
Leukemia; 2008 Feb; 22(2):339-43. PubMed ID: 18046447
[TBL] [Abstract][Full Text] [Related]
3. Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.
Nückel H; Frey UH; Bau M; Sellmann L; Stanelle J; Dürig J; Jöckel KH; Dührsen U; Siffert W
Blood; 2007 Jan; 109(1):290-7. PubMed ID: 16960146
[TBL] [Abstract][Full Text] [Related]
4. Incidence of 5' bcl-2 rearrangement in patients with B cell chronic lymphocytic leukemia from India.
Parikh PM; Desai S; Naresh KN; Shakuntaka B; Laxminarayan K; Nair CN; Ladanyi M; Soman CS; Advani SH; Chaganti RS
Leuk Res; 1996 Sep; 20(9):791-3. PubMed ID: 8947590
[TBL] [Abstract][Full Text] [Related]
5. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
[TBL] [Abstract][Full Text] [Related]
6. The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.
Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Kelava A; Nückel H; Lang S; Schmid KW; Siffert W; Bachmann HS
Ann Oncol; 2009 Jun; 20(6):1094-9. PubMed ID: 19196738
[TBL] [Abstract][Full Text] [Related]
7. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Vargas RL; Felgar RE; Rothberg PG
J Natl Cancer Inst; 2005 Jul; 97(14):1089-90; author reply 1093-5. PubMed ID: 16030309
[No Abstract] [Full Text] [Related]
8. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Iglesias-Serret D; Coll-Mulet L; Santidrián AF; Navarro-Sabaté A; Domingo A; Pons G; Gil J
J Natl Cancer Inst; 2005 Jul; 97(14):1090-1; author reply 1093-5. PubMed ID: 16030310
[No Abstract] [Full Text] [Related]
9. The role of the bax gene polymorphism G(-248)A in chronic lymphocytic leukemia.
Fegan C; Starczynski J; Pratt G; Pepper C
Leukemia; 2006 Aug; 20(8):1460-1. PubMed ID: 16761015
[No Abstract] [Full Text] [Related]
10. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
Calin GA; Pekarsky Y; Croce CM
Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
[TBL] [Abstract][Full Text] [Related]
11. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Dicker F; Rauhut S; Kohlmann A; Kern W; Schoch C; Haferlach T; Schnittger S
J Natl Cancer Inst; 2005 Jul; 97(14):1092-3; author reply 1093-5. PubMed ID: 16030312
[No Abstract] [Full Text] [Related]
12. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Nenning UC; Eckert C; Wellmann S; Barth A; Henze G; Seeger K
J Natl Cancer Inst; 2005 Jul; 97(14):1091-2; author reply 1093-5. PubMed ID: 16030311
[No Abstract] [Full Text] [Related]
13. P2X7 polymorphism and chronic lymphocytic leukaemia.
Mitsiades CS; Mitsiades N
Lancet; 2003 Apr; 361(9367):1478; author reply 1478-9. PubMed ID: 12727428
[No Abstract] [Full Text] [Related]
14. BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.
Zenz T; Benner A; Dührsen U; Dürig J; Döhner H; Siffert W; Stilgenbauer S; Nückel H
Leuk Lymphoma; 2009 Nov; 50(11):1837-42. PubMed ID: 19883311
[TBL] [Abstract][Full Text] [Related]
15. [The expression and prognostic significance of microRNA-34a in Uygur and Han patients with chronic lymphocytic leukemia in Xinjiang Uygur Autonomous Region in China].
Liu H; Wang XM; Mao M; Fu L; Huang Q; Wang YL; Wang YC; Wang ZS; Li Y
Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):922-925. PubMed ID: 30486562
[TBL] [Abstract][Full Text] [Related]
16. [Multidrug resistance in chronic lymphocytic leukemia].
Szendrei T; Magyarlaki T; Kovács G; Nagy A; Szomor A; Molnár L; Dávid M; Tokés-Füzesi M; Rideg O; Pótó L; Pajor L; Kajtár B; Losonczy H
Orv Hetil; 2008 Jan; 149(4):161-7. PubMed ID: 18201958
[TBL] [Abstract][Full Text] [Related]
17. IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
Fang H; Reichard KK; Rabe KG; Hanson CA; Call TG; Ding W; Kenderian SS; Muchtar E; Schwager SM; Leis JF; Chanan-Khan AA; Slager SL; Braggio E; Smoley SA; Kay NE; Shanafelt TD; Van Dyke DL; Parikh SA
Am J Hematol; 2019 Mar; 94(3):338-345. PubMed ID: 30575108
[TBL] [Abstract][Full Text] [Related]
18. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia.
Truger MS; Jeromin S; Weissmann S; Dicker F; Kern W; Schnittger S; Haferlach T; Haferlach C
Br J Haematol; 2015 Jan; 168(1):153-6. PubMed ID: 25135300
[No Abstract] [Full Text] [Related]
20. The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Hoy T; Milligan D; Bentley P; Fegan C
Br J Haematol; 2003 Oct; 123(1):66-71. PubMed ID: 14510944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
